Basal/HER2 breast carcinomas
Work
Year: 2013
Type: article
Abstract: High rates of inherent primary resistance to the humanized monoclonal antibody trastuzumab (Herceptin) are frequent among HER2 gene-amplified breast carcinomas in both metastatic and adjuvant settings... more
Source: Cell Cycle
Authors Begoña Martı́n-Castillo, Cristina Oliveras‐Ferraros, Alejandro Vázquez‐Martín, Sílvia Cufí, José Manuel Moreno +5 more
Institutions Institut d'Investigació Biomèdica de Girona, Catalan Institute for Water Research, Institut Català d'Oncologia, Translational Research Institute, Diputación Foral de Gipuzkoa +4 more
Cites: 177
Cited by: 51
Related to: 10
FWCI: 4.58
Citation percentile (by year/subfield): 94.11
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze